Solid-state cocrystal formation between acyclovir and fumaric acid: Terahertz and Raman vibrational spectroscopic studies

被引:22
作者
Cai, Qiang [1 ]
Xue, Jiadan [2 ]
Wang, Qiqi [1 ]
Du, Yong [1 ]
机构
[1] China Jiliang Univ, Ctr THz Res, Hangzhou 310018, Zhejiang, Peoples R China
[2] Zhejiang Sci Tech Univ, Dept Chem, Hangzhou 310018, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Acyclovir; Fumaric acid; Cocrystal; Terahertz time-domain spectroscopy; Raman spectroscopy; Density functional theory; ORAL BIOAVAILABILITY; POLYMORPHISM; SOLUBILITY; PIRACETAM; COMPOUND; IMPROVE;
D O I
10.1016/j.saa.2017.06.011
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
The vibrational spectra of solid-state acyclovir, fumaric acid and their cocrystal have been investigated by using terahertz time-domain spectroscopy (THz-TDS) and Raman spectroscopy at room temperature. In experimental THz spectra, the cocrystal has absorption peaks in 0.65, 0.94 and 1.10 THz respectively, while the raw materials are absolutely different in this region. Raman spectra also show similar results about differences between the cocrystal and raw materials. Density functional theory (DFT) was performed to simulate vibrational modes of different theoretical forms between acyclovir and fumaric acid. The calculation of theoretical THz spectra shows that O8=C7-N1-H27 and the carboxyl group-COOH establish a dimer theoretical cocrystal form by the hydrogen bonding effect, which makes contributions to the formation of absorption peaks in 0.70, 1.01 and 1.34 THz, and agrees well with experimental observations. The theoretical Raman result also indicates that this dimer form matches with experimental results. The characteristic bands of the cocrystal between acyclovir and fumaric acid are also assigned based on the simulation results from the DFT calculation. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 39 条
  • [1] Alain H., 2009, EUR J PHARM SCI, V38, P156
  • [2] Anindita S., 2015, J PHARM SCI, V104, P98
  • [3] Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Aciclovir
    Arnal, J.
    Gonzalez-Alvarez, I.
    Bermejo, M.
    Amidon, G. L.
    Junginger, H. E.
    Kopp, S.
    Midha, K. K.
    Shah, V. P.
    Stavchansky, S.
    Dressman, J. B.
    Barends, D. M.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (12) : 5061 - 5073
  • [4] Axel D.B., 1996, J CHEM PHYS, V98, P5648
  • [5] Bafour H. H., 1999, NEW ENGL J MED, V340, P1255
  • [6] The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics
    Bak, Annette
    Gore, Anu
    Yanez, Evelyn
    Stanton, Mary
    Tufekcic, Sunita
    Syed, Rashid
    Akrami, Anna
    Rose, Mark
    Surapaneni, Sekhar
    Bostick, Tracy
    King, Anthony
    Neervannan, Sesha
    Ostovic, Drazen
    Koparkar, Arun
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (09) : 3942 - 3956
  • [7] Preparation and characterization of carprofen co-crystals
    Bruni, Giovanna
    Maietta, Mariarosa
    Berbenni, Vittorio
    Bini, Marcella
    Ferrari, Stefania
    Capsoni, Doretta
    Boiocchi, Massimo
    Milanese, Chiara
    Marini, Amedeo
    [J]. CRYSTENGCOMM, 2012, 14 (02): : 435 - 445
  • [8] Sulfa drugs as model cocrystal formers
    Caira, Mino R.
    [J]. MOLECULAR PHARMACEUTICS, 2007, 4 (03) : 310 - 316
  • [9] Density functional study of the optical response of FeN and CoN nitrides with zinc-blend and rock-salt structures
    Cheballah, Y.
    Ziane, A.
    Bouarab, S.
    Vega, A.
    [J]. JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS, 2017, 100 : 148 - 153
  • [10] The role of mechanochemistry and supramolecular design in the development of pharmaceutical materials
    Delori, Amit
    Friscic, Tomislav
    Jones, William
    [J]. CRYSTENGCOMM, 2012, 14 (07): : 2350 - 2362